Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Anaesth ; 113(4): 628-33, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24871873

RESUMO

BACKGROUND: Postoperative haemorrhage in neurosurgery is associated with significant morbidity and mortality. There is controversy whether or not factor XIII (FXIII) deficiency leads to bleeding complications after craniotomy. Decreased fibrinogen levels have been associated with an increased incidence of bleeding complications in cardiac and orthopaedic surgery. The aim of this study was to assess perioperative fibrinogen and FXIII levels in patients undergoing elective intracranial surgery with and without severe bleeding events. METHODS: Perioperative FXIII and fibrinogen levels were prospectively assessed in 290 patients undergoing elective craniotomy. Patients were divided into two groups according to the presence or absence of severe bleeding requiring surgical revision. Coagulation test results of these groups were compared using Student's t-test. RESULTS: The incidence of postoperative severe bleeding was 2.4%. No differences in FXIII levels were observed, but postoperative fibrinogen levels were significantly lower in patients suffering from postoperative haematoma compared with those without postoperative intracranial bleeding complications [237 mg dl(-1) (standard deviation, SD 86) vs 170 mg dl(-1) (SD 35), P=0.03]. The odds ratio for postoperative haematoma in patients with a postoperative fibrinogen level below 200 mg dl(-1) was 10.02 (confidence interval: 1.19-84.40, P=0.03). CONCLUSIONS: This study emphasizes the role of fibrinogen as potentially modifiable risk factor for perioperative bleeding in intracranial surgery. Future randomized controlled trials will be essential to identify patients who might benefit from fibrinogen substitution during neurosurgical procedures.


Assuntos
Afibrinogenemia/complicações , Transtornos de Proteínas de Coagulação/complicações , Craniotomia/efeitos adversos , Fator XIII , Hemorragia Pós-Operatória/epidemiologia , Hemorragia Pós-Operatória/etiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Testes de Coagulação Sanguínea , Intervalos de Confiança , Feminino , Fibrinogênio/análise , Fibrinogênio/metabolismo , Fibrinogênio/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Procedimentos Neurocirúrgicos , Razão de Chances , Tempo de Tromboplastina Parcial , Contagem de Plaquetas , Estudos Prospectivos , Curva ROC , Adulto Jovem
2.
Br J Anaesth ; 104(6): 751-5, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20385572

RESUMO

BACKGROUND: Caudal anaesthesia is a common procedure for infants and children undergoing subumbilical surgery, mostly performed in conjunction with general anaesthesia. Even if complications are rare, the risk of postoperative apnoea is significant, especially in infants born preterm or operated upon before 46 weeks of post-conceptual age. Caudal block in sedated, spontaneously breathing patients might be a safe alternative. METHODS: We investigated 512 infants and children. Premedication consisted of midazolam, sedation was induced with i.v. nalbuphine 0.1 mg kg(-1) and propofol 1 mg kg(-1), and maintained with propofol 5 mg kg(-1) h(-1) in children, if necessary. Caudal block was performed with ropivacaine 1 ml kg(-1) (0.2% or 0.35%). RESULTS: Data were obtained from 228 infants and 284 children. Median (IQR) age was 1.3 (0.2, 3.4) yr; median body weight was 10.0 (4.8, 15.3) kg. Two hundred and thirty-three (45.51%) were born preterm and 47 (9.18%) were operated upon before 46 weeks of post-conceptual age. Caudal block was successful in 98.05% and adverse events occurred in 7.03% patients. The incidence of adverse events was not higher in born preterm or operated upon before 46 weeks of post-conceptual age than in term born infants (P=0.35 and 0.35, respectively), or in infants vs children (P=0.61). There was no correlation between the incidence of adverse events and continuous sedation (P=0.07), coexisting diseases (P=0.11), or ASA classification (P=0.33). CONCLUSIONS: Caudal anaesthesia under sedation is associated with high success rates and a low incidence of adverse events, but requires careful and anticipatory perioperative management.


Assuntos
Anestesia Caudal/métodos , Sedação Consciente/métodos , Abdome/cirurgia , Analgésicos Opioides , Anestesia Caudal/efeitos adversos , Criança , Estudos de Viabilidade , Feminino , Humanos , Hipnóticos e Sedativos , Lactente , Recém-Nascido , Recém-Nascido Prematuro , Masculino , Nalbufina , Pré-Medicação/métodos , Propofol , Estudos Prospectivos
3.
Mycoses ; 47(3-4): 121-30, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15078428

RESUMO

The genus Madurella, described for non-sporulating agents of human mycetoma, is proven to be heterogeneous on the basis of rDNA small subunit (SSU) and Internal Transcribed Spacer (ITS) sequencing data. Madurella mycetomatis, the main agent of mycetoma in arid zones of Central and East Africa, probably belongs to the ascomycete order Sordariales. Madurella mycetomatis, the generic type species, is neotypified. Madurella grisea, with worldwide occurrence, is likely to be a member of the order Pleosporales, just as the mycetoma agents of Leptosphaeria, Pseudochaetosphaeronema, and Pyrenochaeta. Neotestudina rosatii belongs to the order Dothideales. Judging from ITS data, M. mycetomatis and N. rosatii are species complexes. The ex-type strain of N. rosatii, from a human mycetome, has an ITS sequence that deviates from that of environmental strains of the species.


Assuntos
Madurella/classificação , Micetoma/microbiologia , Filogenia , Primers do DNA , DNA Fúngico/análise , DNA Espaçador Ribossômico/genética , Humanos , Madurella/genética , Madurella/isolamento & purificação , Técnicas de Tipagem Micológica , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...